Dr. Bhatt is a veteran of the biotechnology industry with more than 30 years of experience in pharmaceutical development and diagnostics. At Hoffman-La Roche, he developed human IL-2, gamma-Interferon and Human Growth Hormone Releasing Factor pharmaceuticals. He developed a diagnostic for sexually transmitted diseases and the key components of HPA technology, which generate more than $500 million a year in commercial diagnostic revenue for Gen-Probe. For Biocept, Dr. Bhatt developed a non-invasive diagnostic test for fetal RhD genotyping and a fetal gender-determination test from maternal blood at eight to nine weeks gestation. He invented and developed a novel device to capture and analyze circulating fetal cells and tumor cells to diagnose prenatal disorders and cancers. Dr. Bhatt has served as a member of the National Institutes of Health Grant Review Board.
